Read about recent events, essential information and the latest community news.
In partnership with the Andalusian Network for the Design & Translation of Advanced Therapies (ANd&tAT), ISCT is proud to offer this online Educational Program on Advanced Therapy Manufacturing free-of-charge Read more...
The ISCT Early Stage Professionals (ESP) Committee conducted a preliminary job market survey in 2018, as well as a follow-up survey in 2020, to assess the training experience of professionals entering Read more...
The Cellular Therapy Coding and Labeling Advisory Group of the International Council for Commonality in Blood Banking Automation and the International Society for Cell & Gene Therapy mesenchymal stromal Read more...
The ISCT Early Stage Professionals (ESP) Committee is looking for dedicated and enthusiastic new members to join the Committee and support current and upcoming programs. The ISCT ESP Committee is comprised Read more...
The end of the FDA Enforcement Discretion Period for certain human cell, tissue, and tissue-based products (HCT/Ps), including regenerative medicine therapies, marks a new chapter in the regulation Read more...
On-demand access to the 2021 New Orleans Virtual Annual Meeting is available until December 31st, 2021. All presentations, posters, and exhibits will be available for registered delegates. For Read more...
Vancouver, Canada, April 12, 2021 - The International Society for Cell & Gene Therapy (ISCT) , the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated Read more...
World Health Organization Selects ISCT Journal Cytotherapy® to Publish Novel ATMP Official Nomenclature Initiative Official INN assignments to provide proper classification for ATMPs, ensuring safe dispensing Read more...
Vancouver, Canada, March 22, 2021 - The International Society for Cell & Gene Therapy (ISCT) , the global society of clinicians, researchers, regulators, technologists, and industry partners Read more...
For the fourth time, ISCT has been featured prominently in the Cell and Gene Therapy Supplement, published annually by The Medicine Maker . Despite the challenges of 2020, ISCT continues its prominent Read more...